Comparison of skeletal and soft tissue pericytes identifies CXCR4⁺ bone forming mural cells in human tissues

Abstract

Human osteogenic progenitors are not precisely defined, being primarily studied as heterogeneous multipotent cell populations and termed mesenchymal stem cells (MSCs). Notably, select human pericytes can develop into bone-forming osteoblasts. Here, we sought to define the differentiation potential of CD146⁺ human pericytes from skeletal and soft tissue sources, with the underlying goal of defining cell surface markers that typify an osteoblastogenic pericyte. CD146⁺CD31⁻CD45⁻ pericytes were derived by fluorescence-activated cell sorting from human periosteum, adipose, or dermal tissue. Periosteal CD146⁺CD31⁻CD45⁻ cells retained canonical features of pericytes/MSC. Periosteal pericytes demonstrated a striking tendency to undergo osteoblastogenesis in vitro and skeletogenesis in vivo, while soft tissue pericytes did not readily. Transcriptome analysis revealed higher CXCR4 signaling among periosteal pericytes in comparison to their soft tissue counterparts, and CXCR4 chemical inhibition abrogated ectopic ossification by periosteal pericytes. Conversely, enrichment of CXCR4⁺ pericytes or stromal cells identified an osteoblastic/non-adipocytic precursor cell. In sum, human skeletal and soft tissue pericytes differ in their basal abilities to form bone. Diversity exists in soft tissue pericytes, however, and CXCR4⁺ pericytes represent an osteoblastogenic, non-adipocytic cell precursor. Indeed, enrichment for CXCR4-expressing stromal cells is a potential new tactic for skeletal tissue engineering.

References

[1] Birbrair A et al. Pericytes at the intersection between tissue regeneration and pathology. Clin. Sci., 2015, 128:81-93

[2] Meyers CA et al. Pericytes for therapeutic bone repair. Adv. Exp. Med. Biol., 2018, 1109:21-32

[3] James AW et al. Perivascular stem cells: a prospectively purified mesenchymal stem cell population for bone tissue engineering. Stem Cells Transl. Med., 2012, 1:510-519

[4] Kramann R et al. Adventitial MSC-like cells are progenitors of vascular smooth muscle cells and drive vascular calcification in chronic kidney disease. Cell Stem Cell, 2016, 19:628-642

[5] Espagnolle N et al. CD146 expression on mesenchymal stem cells is associated with their vascular smooth muscle commitment. J. Cell Mol. Med., 2014, 18:104-114

[6] Fayazi M, Salehnia M, Ziaei S. In-vitro construction of endometrial-like epithelium using CD146(+) mesenchymal cells derived from human endometrium. Reprod. Biomed. Online, 2017, 35:241-252

[7] Crisan M et al. A perivascular origin for mesenchymal stem cells in multiple human organs. Cell Stem Cell, 2008, 3:301-313

[8] Russell KC et al. Cell-surface expression of neuron-glial antigen 2 (NG2) and melanoma cell adhesion molecule (CD146) in heterogeneous cultures of marrow-derived mesenchymal stem cells. Tissue Eng. Part A, 2013, 19:2253-2266

[9] Hindle P, Khan N, Biant L, Peault B. The infrapatellar fat pad as a source of perivascular stem cells with Increased chondrogenic potential for regenerative medicine. Stem Cells Transl. Med., 2017, 6:77-87

[10] Shi S, Gronthos S. Perivascular niche of postnatal mesenchymal stem cells in human bone marrow and dental pulp. J. Bone Miner. Res., 2003, 18:696-704

[11] Tavazoie M et al. A specialized vascular niche for adult neural stem cells. Cell Stem Cell, 2008, 3:279-288

[12] Cai W et al. Pericytes in brain injury and repair after ischemic stroke. Transl. Stroke Res, 2017, 8:107-121

[13] Stefanska A et al. Human kidney pericytes produce renin. Kidney Int, 2016, 90:1251-1261

[14] Xu J, Wang W, Kapila Y, Lotz J, Kapila S. Multiple differentiation capacity of STRO-1+/CD146+ PDL mesenchymal progenitor cells. Stem Cells Dev., 2009, 18:487-496

[15] Sorrentino A et al. Isolation and characterization of CD146+ multipotent mesenchymal stromal cells. Exp. Hematol., 2008, 36:1035-1046

[16] Ulrich C et al. Human placenta-derived CD146-positive mesenchymal stromal cells display a distinct osteogenic differentiation potential. Stem Cells Dev., 2015, 24:1558-1569

[17] Meyers CA et al. Early immunomodulatory effects of implanted human perivascular stromal cells during bone formation. Tissue Eng. Part A, 2018, 24:448-457

[18] Lee S et al. Brief report: human perivascular stem cells and Nel-Like Protein-1 synergistically enhance spinal fusion in osteoporotic rats. Stem Cells, 2015, 33:3158-3163

[19] James AW et al. An abundant perivascular source of stem cells for bone tissue engineering. Stem Cells Transl. Med., 2012, 1:673-684

[20] James, A. W. et al. Use of human perivascular stem cells for bone regeneration. J. Vis. Exp. e2952 (2012).

[21] Askarinam A et al. Human perivascular stem cells show enhanced osteogenesis and vasculogenesis with Nel-like molecule I protein. Tissue Eng. Part A, 2013, 19:1386-1397

[22] Chung CG et al. Human perivascular stem cell-based bone graft substitute induces rat spinal fusion. Stem Cells Transl. Med., 2014, 3:1231-1241

[23] Tawonsawatruk T et al. Adipose derived pericytes rescue fractures from a failure of healing–non-union. Sci. Rep., 2016, 6

[24] James AW et al. Pericytes for the treatment of orthopedic conditions. Pharm. Ther., 2017, 171:93-103

[25] James AW, Peault B. Perivascular mesenchymal progenitors for bone regeneration. J. Orthop. Res., 2019, 37:1221-1228

[26] Diaz-Flores L, Gutierrez R, Gonzalez P, Varela H. Inducible perivascular cells contribute to the neochondrogenesis in grafted perichondrium. Anat. Rec., 1991, 229:1-8

[27] Diaz-Flores L, Gutierrez R, Lopez-Alonso A, Gonzalez R, Varela H. Pericytes as a supplementary source of osteoblasts in periosteal osteogenesis. Clin. Orthop. Relat. Res, 1992, 275:280-286

[28] Matthews BG et al. Analysis of alphaSMA-labeled progenitor cell commitment identifies notch signaling as an important pathway in fracture healing. J. Bone Min. Res., 2014, 29:1283-1294

[29] Supakul S et al. Pericytes as a source of osteogenic cells in bone fracture healing. Int. J. Mol. Sci., 2019, 20:pii: E1079

[30] Zhou BO, Yue R, Murphy MM, Peyer JG, Morrison SJ. Leptin-receptor-expressing mesenchymal stromal cells represent the main source of bone formed by adult bone marrow. Cell Stem Cell, 2014, 15:154-168

[31] Xie L, Zeng X, Hu J, Chen Q. Characterization of nestin, a selective marker for bone marrow derived mesenchymal stem cells. Stem Cells Int., 2015, 2015:762098

[32] Schugar RC et al. High harvest yield, high expansion, and phenotype stability of CD146 mesenchymal stromal cells from whole primitive human umbilical cord tissue. J. Biomed. Biotechnol., 2009, 2009:789526

[33] Covas DT et al. Multipotent mesenchymal stromal cells obtained from diverse human tissues share functional properties and gene-expression profile with CD146+ perivascular cells and fibroblasts. Exp. Hematol., 2008, 36:642-654

[34] Dvoretskiy S et al. The impact of skeletal muscle contraction on CD146(+)Lin(-) pericytes. Am. J. Physiol. Cell Physiol., 2019, 317:C1011-C1024

[35] Cho KA, Park M, Kim YH, Woo SY, Ryu KH. RNA sequencing reveals a transcriptomic portrait of human mesenchymal stem cells from bone marrow, adipose tissue, and palatine tonsils. Sci. Rep., 2017, 7

[36] Zhu W et al. A novel regulatory role for stromal-derived factor-1 signaling in bone morphogenic protein-2 osteogenic differentiation of mesenchymal C2C12 cells. J. Biol. Chem., 2007, 282:18676-18685

[37] Brunner M et al. beta1 integrins mediate the BMP2 dependent transcriptional control of osteoblast differentiation and osteogenesis. PLoS ONE, 2018, 13

[38] Beederman M et al. BMP signaling in mesenchymal stem cell differentiation and bone formation. J. Biomed. Sci. Eng., 2013, 6:32-52

[39] Seo JB et al. Activated liver X receptors stimulate adipocyte differentiation through induction of peroxisome proliferator-activated receptor gamma expression. Mol. Cell Biol., 2004, 24:3430-3444

[40] Ma X, Wang D, Zhao W, Xu L. Deciphering the roles of PPARgamma in adipocytes via dynamic change of transcription complex. Front Endocrinol., 2018, 9:473

[41] Richard AJ, Stephens JM. The role of JAK-STAT signaling in adipose tissue function. Biochim Biophys. Acta, 2014, 1842:431-439

[42] Ussar S, Bezy O, Bluher M, Kahn CR. Glypican-4 enhances insulin signaling via interaction with the insulin receptor and serves as a novel adipokine. Diabetes, 2012, 61:2289-2298

[43] Merrick D et al. Identification of a mesenchymal progenitor cell hierarchy in adipose tissue. Science, 2019, 364:pii: eaav2501

[44] Levi B et al. Human adipose derived stromal cells heal critical size mouse calvarial defects. PLoS ONE, 2010, 5

[45] Shore EM et al. Paternally inherited inactivating mutations of the GNAS1 gene in progressive osseous heteroplasia. N. Engl. J. Med., 2002, 346:99-106

[46] Saxer F et al. Implantation of stromal vascular fraction progenitors at bone fracture sites: from a rat model to a first-in-man study. Stem Cells, 2016, 34:2956-2966

[47] Stratman AN, Malotte KM, Mahan RD, Davis MJ, Davis GE. Pericyte recruitment during vasculogenic tube assembly stimulates endothelial basement membrane matrix formation. Blood, 2009, 114:5091-5101

[48] Kumagai K, Vasanji A, Drazba JA, Butler RS, Muschler GF. Circulating cells with osteogenic potential are physiologically mobilized into the fracture healing site in the parabiotic mice model. J. Orthop. Res., 2008, 26:165-175

[49] Rapp AE et al. Systemic mesenchymal stem cell administration enhances bone formation in fracture repair but not load-induced bone formation. Eur. Cell Mater., 2015, 29:22-34

[50] Huang S, Xu L, Sun Y, Zhang Y, Li G. The fate of systemically administrated allogeneic mesenchymal stem cells in mouse femoral fracture healing. Stem Cell Res. Ther., 2015, 6:206

[51] Levi B et al. Studies in adipose-derived stromal cells: migration and participation in repair of cranial injury after systemic injection. Plast. Reconstr. Surg., 2011, 127:1130-1140

[52] Lugassy C et al. Pilot study on “pericytic mimicry” and potential embryonic/stem cell properties of angiotropic melanoma cells interacting with the abluminal vascular surface. Cancer Microenviron., 2013, 6:19-29

[53] Mravic M et al. From pericytes to perivascular tumours: correlation between pathology, stem cell biology, and tissue engineering. Int. Orthop., 2014, 38:1819-1824

[54] Tang W et al. White fat progenitor cells reside in the adipose vasculature. Science, 2008, 322:583-586

[55] Kramann R et al. Perivascular Gli1+ progenitors are key contributors to injury-induced organ fibrosis. Cell Stem Cell, 2015, 16:51-66

[56] Murray IR et al. alphav integrins on mesenchymal cells regulate skeletal and cardiac muscle fibrosis. Nat. Commun., 2017, 8

[57] Zhao H et al. Secretion of shh by a neurovascular bundle niche supports mesenchymal stem cell homeostasis in the adult mouse incisor. Cell Stem Cell, 2014, 14:160-173

[58] Dellavalle A et al. Pericytes resident in postnatal skeletal muscle differentiate into muscle fibres and generate satellite cells. Nat. Commun., 2011, 2

[59] Corselli M et al. Perivascular support of human hematopoietic stem/progenitor cells. Blood, 2013, 121:2891-2901

[60] West CC et al. Prospective purification of perivascular presumptive mesenchymal stem cells from human adipose tissue: process optimization and cell population metrics across a large cohort of diverse demographics. Stem Cell Res. Ther., 2016, 7:47

[61] Zeng Q et al. CD146, an epithelial-mesenchymal transition inducer, is associated with triple-negative breast cancer. Proc. Natl Acad. Sci. USA, 2012, 109:1127-1132

[62] Liu X et al. SDF-1 promotes endochondral bone repair during fracture healing at the traumatic brain injury condition. PLoS ONE, 2013, 8

Funding

U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)(R01 AR070773)

U.S. Department of Health & Human Services | NIH | National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)

U.S. Department of Health & Human Services | NIH | National Institute of Dental and Craniofacial Research (NIDCR)(R21 DE027922)

U.S. Department of Defense (United States Department of Defense)(W81XWH-18-1-0121)

American Cancer Society (American Cancer Society, Inc.)(RSG-18-027-01-CSM)

The Maryland Stem Cell Research Foundation, and the Musculoskeletal Transplant Foundation